Cue Biopharma, Inc. (CUE)
27.44
-0.23
(-0.83%)
USD |
NASDAQ |
Sep 04, 16:00
27.34
-0.10
(-0.36%)
After-Hours: 20:00
Cue Biopharma Research and Development Expense (Quarterly) : 48.98M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 48.98M |
| March 31, 2026 | 6.828M |
| December 31, 2025 | 16.47M |
| September 30, 2025 | 4.686M |
| June 30, 2025 | 7.817M |
| March 31, 2025 | 8.454M |
| December 31, 2024 | 7.184M |
| September 30, 2024 | 9.381M |
| June 30, 2024 | 9.53M |
| March 31, 2024 | 10.20M |
| December 31, 2023 | 10.79M |
| September 30, 2023 | 9.748M |
| June 30, 2023 | 10.52M |
| March 31, 2023 | 9.222M |
| December 31, 2022 | 11.20M |
| September 30, 2022 | 7.28M |
| June 30, 2022 | 9.381M |
| March 31, 2022 | 9.802M |
| December 31, 2021 | 11.50M |
| Date | Value |
|---|---|
| September 30, 2021 | 11.00M |
| June 30, 2021 | 8.473M |
| March 31, 2021 | 9.528M |
| December 31, 2020 | 7.772M |
| September 30, 2020 | 7.274M |
| June 30, 2020 | 7.873M |
| March 31, 2020 | 9.667M |
| December 31, 2019 | 6.756M |
| September 30, 2019 | 5.061M |
| June 30, 2019 | 6.628M |
| March 31, 2019 | 8.159M |
| December 31, 2018 | 6.628M |
| September 30, 2018 | 10.13M |
| June 30, 2018 | 5.228M |
| March 31, 2018 | 5.66M |
| December 31, 2017 | 8.898M |
| September 30, 2017 | 3.882M |
| September 30, 2016 | 1.345M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 21.96M |
| Fortress Biotech, Inc. | 0.805M |
| Equillium, Inc. | 2.749M |
| Legend Biotech Corp. | 96.16M |
| Nurix Therapeutics, Inc. | 85.40M |